Lv1
28 积分 2024-11-11 加入
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
2小时前
待确认
In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction
1个月前
已关闭
Update on cutaneous lupus erythematosus pathogenesis, diagnosis and management
1个月前
已完结
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
1个月前
已完结
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne
1个月前
已完结
About two cases of ulcerative inflammation of the small intestine
2个月前
已关闭
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
2个月前
已完结
Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial
3个月前
已完结
Development and validation of the fingertip unit for assessing Facial Vitiligo Area Scoring Index
6个月前
已完结
Parametric Modeling of Narrowband UV-B Phototherapy for Vitiligo Using a Novel Quantitative Tool
6个月前
已完结
皖公网安备34019202002308
